APOA1 and neoplasm: Tumor control was associated with a reduced cholesterol levels in the TME, as evidenced by lower cholesterol levels in TIFs of mice bearing APOA1-expressing GBMs compared to those bearing puromycin-expressing GBMs (Fig. 3f).